2024-03-27 16:05:32 ET
Summary
- Inari Medical, Inc.'s share price has dropped due to an investigation on doctor payment practices, creating a buying opportunity for risk-willing investors.
- Inari creates mechanical thrombectomy products for VTE and PE, with high potential operating margins and strong growth.
- Emerging products are now broken out on earnings, as Inari leans into their next phase of growth with a larger total addressable market.
Inari Medical, Inc. ( NARI ) is the leader in treatment of VTE, or venous thromboembolism. Inari is one of the top medical device stocks to own for 2024 for those with high risk tolerance due to high growth rate and the now cheap valuation....
Read the full article on Seeking Alpha
For further details see:
Inari Medical: Buy On Growing TAM